Event Information:
Dates
November 4th to 6th, 2024
Location
Stockholm, Sweden
Related Models
TransCure BioServices at Bio Europe Fall 2024
We are excited to announce that Sebastien Tabruyn, our CEO, will be attending Bio Europe 2024 from November 4-6, 2024, in Stockholm, Sweden.
Bio Europe is a premier event that brings together leaders from the biotechnology and pharmaceutical industries to explore the latest advancements and forge new collaborations. This is an excellent opportunity for us to engage with partners and discuss how TransCure BioServices is advancing preclinical research through the use of humanized mouse models.
Sebastien will be available to discuss how our models, including the CD34+ humanized immune system mice, humanized liver mice (hu-liver), and dual humanized models, are being used to accelerate research in areas such as immuno-oncology, gene therapy, and liver diseases.
If you are attending Bio Europe, don’t miss the opportunity to meet with Sebastien and learn how we can support your preclinical studies and help advance therapeutic innovations.
For more information about the event and to register, visit: https://informaconnect.com/bioeurope/
To book a meeting with Sebastien Tabruyn:
Attending in person for TransCure BioServices:
Sebastien Tabruyn, PhD, CEO
Sebastien Tabruyn holds a PhD in Molecular Biology from the University of Liege (Belgium). With over 20 years of experience as a Project Leader in worldwide academic research institutes, including UCSF (California, USA), the Centre for Cancer Biology (Adelaide, Australia), and the University of Maastricht (Netherlands), Sebastien joined TransCure bioServices in 2013 to develop the first immune-oncology humanized mouse models. Before taking on the role of CEO, Sebastien served as the company’s Chief Scientific Officer for six years, where he was instrumental in driving scientific excellence and innovation. Sebastien Tabruyn has published more than 35 peer-reviewed publications, primarily focusing on oncology, inflammation, immunity, and angiogenesis. As CEO, Sebastien commits his leadership and vision to the expansion of TransCure bioServices through the successful delivery of its client needs.